Jiafei Lin

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Development and Validation of a User-Friendly Predictive Model Using Demographic and Complete Blood Count Data to Facilitate Early Diagnosis on Suspicion of Myeloproliferative Neoplasms.

Development and Validation of a User-Friendly Predictive Model Using Demographic and Complete Blood Count Data to Facilitate Early Diagnosis on Suspicion of Myeloproliferative Neoplasms.

Journal: International journal of laboratory hematology

Published: September 21, 2024

Superior detection of low-allele burden Janus kinase 2 V617F mutation and monitoring clonal evolution in myeloproliferative neoplasms using chip-based digital PCR.

Superior detection of low-allele burden Janus kinase 2 V617F mutation and monitoring clonal evolution in myeloproliferative neoplasms using chip-based digital PCR.

Journal: Annals of hematology

Published: April 16, 2024

Correction: CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.

Correction: CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.

Journal: Cell death & disease

Published: July 12, 2022

Overexpression of TRAF4 promotes lung cancer growth and EGFR-dependent phosphorylation of ERK5.

Overexpression of TRAF4 promotes lung cancer growth and EGFR-dependent phosphorylation of ERK5.

Journal: FEBS open bio

Published: January 19, 2022

The circular RNA circ_GRHPR promotes NSCLC cell proliferation and invasion via interactions with the RNA-binding protein PCBP2.

The circular RNA circ_GRHPR promotes NSCLC cell proliferation and invasion via interactions with the RNA-binding protein PCBP2.

Journal: Clinical and experimental pharmacology & physiology

Published: April 06, 2021

RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer.

RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer.

Journal: Cancer cell international

Published: September 18, 2020

Inflammation accelerates copper-mediated cytotoxicity through induction of six-transmembrane epithelial antigens of prostate 4 expression.

Inflammation accelerates copper-mediated cytotoxicity through induction of six-transmembrane epithelial antigens of prostate 4 expression.

Journal: Immunology and cell biology

Published: January 30, 2020

CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.

CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.

Journal: Cell death & disease

Published: April 07, 2019

Serum CD166: a novel hepatocellular carcinoma tumor marker.

Serum CD166: a novel hepatocellular carcinoma tumor marker.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: May 20, 2014

New insights into FAK phosphorylation based on a FAT domain-defective mutation.

New insights into FAK phosphorylation based on a FAT domain-defective mutation.

Journal: PloS one

Published: April 20, 2014

Cluster of differentiation 166 (CD166) regulated by phosphatidylinositide 3-Kinase (PI3K)/AKT signaling to exert its anti-apoptotic role via yes-associated protein (YAP) in liver cancer.

Cluster of differentiation 166 (CD166) regulated by phosphatidylinositide 3-Kinase (PI3K)/AKT signaling to exert its anti-apoptotic role via yes-associated protein (YAP) in liver cancer.

Journal: The Journal of biological chemistry

Published: February 01, 2014

B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function.

B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function.

Journal: Journal of gastroenterology

Published: July 12, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026